Regenerative biotechnology
Gencell® Renal Stabilizer
Mesenchymal stem cells pretreated with melatonin for renal regenerative support.
Injectable solution of mesenchymal stem cells pretreated with melatonin, with immunomodulatory, antioxidant, and regenerative properties, indicated as an adjunct in renal, inflammatory, infectious, and systemic conditions.
Composition
Mesenchymal stem cells pretreated with melatonin.
Pharmaceutical form
Injectable solution.
Presentation
Monovette with 4 ml.
Therapeutic Properties
They promote tissue repair through immunomodulation, reduction of inflammation, inhibition of apoptosis, antioxidant activation, secretion of regenerative factors, and cellular stabilization, enhanced by pretreatment with melatonin.
- Reduction of systemic inflammation.
- Modulation of the immune response.
- Cellular antioxidant protection.
- Inhibition of tissue apoptosis.
- Stimulation of renal regeneration.
- Stabilization of cellular membranes.
- Activation of regenerative pathways.
- Support for accelerated tissue recovery.
Mechanism of action & Clinical data
They migrate to the site of injury, modulate inflammation, inhibit apoptosis, and release antioxidant and regenerative factors induced by melatonin.